{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:51:34Z","timestamp":1778759494754,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The basic applied research projects in Shanxi Province","award":["201601D021156"],"award-info":[{"award-number":["201601D021156"]}]},{"name":"The Scientific Research Fund of Shanxi Cardiovascular Hospital","award":["20170203"],"award-info":[{"award-number":["20170203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10741-019-09800-6","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:14:34Z","timestamp":1557299674000},"page":"941-948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Advances in research on treatment of heart failure with nitrosyl hydrogen"],"prefix":"10.1007","volume":"24","author":[{"given":"Yanqing","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8006-0625","authenticated-orcid":false,"given":"Jian","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"9800_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jinorgbio.2012.08.027","volume":"118","author":"JM Fukuto","year":"2013","unstructured":"Fukuto JM, Cisneros CJ, Kinkade RL (2013) A comparison of the chemistry associated with the biological signaling and actions of nitroxyl (HNO) and nitric oxide (NO). J Inorg Biochem 118:201\u2013208. \nhttps:\/\/doi.org\/10.1016\/j.jinorgbio.2012.08.027","journal-title":"J Inorg Biochem"},{"key":"9800_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/circheartfailure.113.000632","volume":"6","author":"HN Sabbah","year":"2013","unstructured":"Sabbah HN, Tocchetti CG, Wang M, Daya S, Gupta RC, Tunin RS, Mazhari R, Takimoto E, Paolocci N, Cowart D, Colucci WS, Kass DA (2013) Nitroxyl (HNO): a novel approach for the acute treatment of heart failure. Circ Heart Fail 6:1250\u20131258. \nhttps:\/\/doi.org\/10.1161\/circheartfailure.113.000632","journal-title":"Circ Heart Fail"},{"key":"9800_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.RES.0000253904.53601.c9","volume":"100","author":"CG Tocchetti","year":"2007","unstructured":"Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, di Benedetto G, O\u2019Rourke B, Gao WD, Wink DA, Toscano JP, Zaccolo M, Bers DM, Valdivia HH, Cheng H, Kass DA, Paolocci N (2007) Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res 100:96\u2013104. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000253904.53601.c9","journal-title":"Circ Res"},{"key":"9800_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.phrs.2015.12.006","volume":"104","author":"KY Chin","year":"2016","unstructured":"Chin KY, Michel L, Qin CX, Cao N, Woodman OL, Ritchie RH (2016) The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo. Pharmacol Res 104:165\u2013175. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2015.12.006","journal-title":"Pharmacol Res"},{"key":"9800_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/hypertensionaha.114.04285","volume":"65","author":"G Zhu","year":"2015","unstructured":"Zhu G, Groneberg D, Sikka G, Hori D, Ranek MJ, Nakamura T, Takimoto E, Paolocci N, Berkowitz DE, Friebe A, Kass DA (2015) Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse. Hypertension 65:385\u2013392. \nhttps:\/\/doi.org\/10.1161\/hypertensionaha.114.04285","journal-title":"Hypertension"},{"key":"9800_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.niox.2013.08.006","volume":"35","author":"RF Dautov","year":"2013","unstructured":"Dautov RF, Ngo DT, Licari G, Liu S, Sverdlov AL, Ritchie RH et al (2013) The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness. Nitric Oxide 35:72\u201378. \nhttps:\/\/doi.org\/10.1016\/j.niox.2013.08.006","journal-title":"Nitric Oxide"},{"key":"9800_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ejhf.50","volume":"16","author":"CG Tocchetti","year":"2014","unstructured":"Tocchetti CG, Carpi A, Coppola C, Quintavalle C, Rea D, Campesan M, Arcari A, Piscopo G, Cipresso C, Monti MG, de Lorenzo C, Arra C, Condorelli G, di Lisa F, Maurea N (2014) Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction. Eur J Heart Fail 16:358\u2013366. \nhttps:\/\/doi.org\/10.1002\/ejhf.50","journal-title":"Eur J Heart Fail"},{"key":"9800_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1152\/physiol.00019.2006","volume":"21","author":"DM Bers","year":"2006","unstructured":"Bers DM (2006) Altered cardiac myocyte ca regulation in heart failure. Physiology (Bethesda) 21:380\u2013387. \nhttps:\/\/doi.org\/10.1152\/physiol.00019.2006","journal-title":"Physiology (Bethesda)"},{"key":"9800_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.RES.0000258172.74570.e6","volume":"100","author":"J Curran","year":"2007","unstructured":"Curran J, Hinton MJ, Rios E, Bers DM, Shannon TR (2007) Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium\/calmodulin-dependent protein kinase. Circ Res 100:391\u2013398. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000258172.74570.e6","journal-title":"Circ Res"},{"key":"9800_CR10","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.1073\/pnas.1513047112","volume":"112","author":"G Santulli","year":"2015","unstructured":"Santulli G, Xie W, Reiken SR, Marks AR (2015) Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci U S A 112:11389\u201311394. \nhttps:\/\/doi.org\/10.1073\/pnas.1513047112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9800_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00424-008-0506-5","volume":"457","author":"E Vafiadaki","year":"2009","unstructured":"Vafiadaki E, Papalouka V, Arvanitis DA, Kranias EG, Sanoudou D (2009) The role of SERCA2a\/PLN complex, ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate. Pflugers Arch 457:687\u2013700. \nhttps:\/\/doi.org\/10.1007\/s00424-008-0506-5","journal-title":"Pflugers Arch"},{"key":"9800_CR12","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/eurheartj\/ehr026","volume":"32","author":"G Hasenfuss","year":"2011","unstructured":"Hasenfuss G, Teerlink JR (2011) Cardiac inotropes: current agents and future directions. Eur Heart J 32:1838\u20131845. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehr026","journal-title":"Eur Heart J"},{"key":"9800_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ejhf.62","volume":"16","author":"G Tarone","year":"2014","unstructured":"Tarone G, Balligand JL, Bauersachs J, Clerk A, De Windt L, Heymans S et al (2014) Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the working group on myocardial function of the European Society of Cardiology. Eur J Heart Fail 16:494\u2013508. \nhttps:\/\/doi.org\/10.1002\/ejhf.62","journal-title":"Eur J Heart Fail"},{"key":"9800_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/fjc.0000000000000113","volume":"64","author":"L Nagy","year":"2014","unstructured":"Nagy L, Pollesello P, Papp Z (2014) Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus. J Cardiovasc Pharmacol 64:199\u2013208. \nhttps:\/\/doi.org\/10.1097\/fjc.0000000000000113","journal-title":"J Cardiovasc Pharmacol"},{"key":"9800_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/ars.2010.3198","volume":"14","author":"C Nediani","year":"2011","unstructured":"Nediani C, Raimondi L, Borchi E, Cerbai E (2011) Nitric oxide\/reactive oxygen species generation and nitroso\/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal 14:289\u2013331. \nhttps:\/\/doi.org\/10.1089\/ars.2010.3198","journal-title":"Antioxid Redox Signal"},{"key":"9800_CR16","doi-asserted-by":"publisher","first-page":"H365","DOI":"10.1152\/ajpheart.00495.2012","volume":"305","author":"JC Irvine","year":"2013","unstructured":"Irvine JC, Cao N, Gossain S, Alexander AE, Love JE, Qin C, Horowitz JD, Kemp-Harper BK, Ritchie RH (2013) HNO\/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. Am J Physiol Heart Circ Physiol 305:H365\u2013H377. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00495.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9800_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/circheartfailure.114.001699","volume":"8","author":"N Cao","year":"2015","unstructured":"Cao N, Wong YG, Rosli S, Kiriazis H, Huynh K, Qin C, du XJ, Kemp-Harper BK, Ritchie RH (2015) Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo. Circ Heart Fail 8:572\u2013581. \nhttps:\/\/doi.org\/10.1161\/circheartfailure.114.001699","journal-title":"Circ Heart Fail"},{"key":"9800_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043313","volume":"7","author":"C Zgheib","year":"2012","unstructured":"Zgheib C, Kurdi M, Zouein FA, Gunter BW, Stanley BA, Zgheib J, Romero DG, King SB, Paolocci N, Booz GW (2012) Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive. PLoS One 7:e43313. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0043313","journal-title":"PLoS One"},{"key":"9800_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034892","volume":"7","author":"EQ Lin","year":"2012","unstructured":"Lin EQ, Irvine JC, Cao AH, Alexander AE, Love JE, Patel R, McMullen JR, Kaye DM, Kemp-Harper BK, Ritchie RH (2012) Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. PLoS One 7:e34892. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0034892","journal-title":"PLoS One"},{"key":"9800_CR20","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1111\/bph.12568","volume":"171","author":"KY Chin","year":"2014","unstructured":"Chin KY, Qin C, Cao N, Kemp-Harper BK, Woodman OL, Ritchie RH (2014) The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. Br J Pharmacol 171:1722\u20131734. \nhttps:\/\/doi.org\/10.1111\/bph.12568","journal-title":"Br J Pharmacol"},{"key":"9800_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s0076-6879(07)00826-9","volume":"440","author":"JM Fukuto","year":"2008","unstructured":"Fukuto JM, Jackson MI, Kaludercic N, Paolocci N (2008) Examining nitroxyl in biological systems. Methods Enzymol 440:411\u2013431. \nhttps:\/\/doi.org\/10.1016\/s0076-6879(07)00826-9","journal-title":"Methods Enzymol"},{"key":"9800_CR22","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/bph.12451","volume":"170","author":"SP Alexander","year":"2013","unstructured":"Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M et al (2013) The concise guide to PHARMACOLOGY 2013\/14: enzymes. Br J Pharmacol 170:1797\u20131867. \nhttps:\/\/doi.org\/10.1111\/bph.12451","journal-title":"Br J Pharmacol"},{"key":"9800_CR23","doi-asserted-by":"publisher","first-page":"7387","DOI":"10.1021\/bi401110f","volume":"52","author":"G Keceli","year":"2013","unstructured":"Keceli G, Moore CD, Labonte JW, Toscano JP (2013) NMR detection and study of hydrolysis of HNO-derived sulfinamides. Biochemistry 52:7387\u20137396. \nhttps:\/\/doi.org\/10.1021\/bi401110f","journal-title":"Biochemistry"},{"key":"9800_CR24","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1021\/ic902319d","volume":"49","author":"MR Kumar","year":"2010","unstructured":"Kumar MR, Fukuto JM, Miranda KM, Farmer PJ (2010) Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects. Inorg Chem 49:6283\u20136292. \nhttps:\/\/doi.org\/10.1021\/ic902319d","journal-title":"Inorg Chem"},{"key":"9800_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00726-010-0508-4","volume":"41","author":"N Nagahara","year":"2011","unstructured":"Nagahara N (2011) Intermolecular disulfide bond to modulate protein function as a redox-sensing switch. Amino Acids 41:59\u201372. \nhttps:\/\/doi.org\/10.1007\/s00726-010-0508-4","journal-title":"Amino Acids"},{"key":"9800_CR26","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1089\/ars.2010.3855","volume":"14","author":"JM Fukuto","year":"2011","unstructured":"Fukuto JM, Carrington SJ (2011) HNO signaling mechanisms. Antioxid Redox Signal 14:1649\u20131657. \nhttps:\/\/doi.org\/10.1089\/ars.2010.3855","journal-title":"Antioxid Redox Signal"},{"key":"9800_CR27","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1089\/ars.2010.3859","volume":"14","author":"CG Tocchetti","year":"2011","unstructured":"Tocchetti CG, Stanley BA, Murray CI, Sivakumaran V, Donzelli S, Mancardi D, Pagliaro P, Gao WD, van Eyk J, Kass DA, Wink DA, Paolocci N (2011) Playing with cardiac \u201credox switches\u201d: the \u201cHNO way\u201d to modulate cardiac function. Antioxid Redox Signal 14:1687\u20131698. \nhttps:\/\/doi.org\/10.1089\/ars.2010.3859","journal-title":"Antioxid Redox Signal"},{"key":"9800_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s1063-5823(10)66005-x","volume":"66","author":"G Meissner","year":"2010","unstructured":"Meissner G (2010) Regulation of ryanodine receptor ion channels through posttranslational modifications. Curr Top Membr 66:91\u2013113. \nhttps:\/\/doi.org\/10.1016\/s1063-5823(10)66005-x","journal-title":"Curr Top Membr"},{"key":"9800_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/circresaha.112.278416","volume":"111","author":"Y Ge","year":"2012","unstructured":"Ge Y, Moss RL (2012) Nitroxyl, redox switches, cardiac myofilaments, and heart failure: a prequel to novel therapeutics? Circ Res 111:954\u2013956. \nhttps:\/\/doi.org\/10.1161\/circresaha.112.278416","journal-title":"Circ Res"},{"key":"9800_CR30","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/ars.2012.5057","volume":"19","author":"V Sivakumaran","year":"2013","unstructured":"Sivakumaran V, Stanley BA, Tocchetti CG, Ballin JD, Caceres V, Zhou L, Keceli G, Rainer PP, Lee DI, Huke S, Ziolo MT, Kranias EG, Toscano JP, Wilson GM, O'Rourke B, Kass DA, Mahaney JE, Paolocci N (2013) HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization. Antioxid Redox Signal 19:1185\u20131197. \nhttps:\/\/doi.org\/10.1089\/ars.2012.5057","journal-title":"Antioxid Redox Signal"},{"key":"9800_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.abb.2005.07.012","volume":"442","author":"BE Lopez","year":"2005","unstructured":"Lopez BE, Rodriguez CE, Pribadi M, Cook NM, Shinyashiki M, Fukuto JM (2005) Inhibition of yeast glycolysis by nitroxyl (HNO): mechanism of HNO toxicity and implications to HNO biology. Arch Biochem Biophys 442:140\u2013148. \nhttps:\/\/doi.org\/10.1016\/j.abb.2005.07.012","journal-title":"Arch Biochem Biophys"},{"key":"9800_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ceca.2004.07.001","volume":"37","author":"E Cheong","year":"2005","unstructured":"Cheong E, Tumbev V, Abramson J, Salama G, Stoyanovsky DA (2005) Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37:87\u201396. \nhttps:\/\/doi.org\/10.1016\/j.ceca.2004.07.001","journal-title":"Cell Calcium"},{"issue":"43","key":"9800_CR33","doi-asserted-by":"publisher","first-page":"33554","DOI":"10.1074\/jbc.M004337200","volume":"275","author":"Subrata Adak","year":"2000","unstructured":"Adak S, Wang Q, Stuehr DJ (2000) Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism. J Biol Chem 275:33554\u201333561. \nhttps:\/\/doi.org\/10.1074\/jbc.M004337200","journal-title":"Journal of Biological Chemistry"},{"key":"9800_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1089\/ars.2010.3838","volume":"14","author":"JF DuMond","year":"2011","unstructured":"DuMond JF, King SB (2011) The chemistry of nitroxyl-releasing compounds. Antioxid Redox Signal 14:1637\u20131648. \nhttps:\/\/doi.org\/10.1089\/ars.2010.3838","journal-title":"Antioxid Redox Signal"},{"key":"9800_CR35","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1021\/ja045480z","volume":"127","author":"KM Miranda","year":"2005","unstructured":"Miranda KM, Dutton AS, Ridnour LA, Foreman CA, Ford E, Paolocci N, Katori T, Tocchetti CG, Mancardi D, Thomas DD, Espey MG, Houk KN, Fukuto JM, Wink DA (2005) Mechanism of aerobic decomposition of Angeli\u2019s salt (sodium trioxodinitrate) at physiological pH. J Am Chem Soc 127:722\u2013731. \nhttps:\/\/doi.org\/10.1021\/ja045480z","journal-title":"J Am Chem Soc"},{"key":"9800_CR36","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1021\/jm050151i","volume":"48","author":"KM Miranda","year":"2005","unstructured":"Miranda KM, Katori T, Torres de Holding CL, Thomas L, Ridnour LA, McLendon WJ et al (2005) Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo. J Med Chem 48:8220\u20138228. \nhttps:\/\/doi.org\/10.1021\/jm050151i","journal-title":"J Med Chem"},{"key":"9800_CR37","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/circresaha.112.270827","volume":"111","author":"WD Gao","year":"2012","unstructured":"Gao WD, Murray CI, Tian Y, Zhong X, DuMond JF, Shen X et al (2012) Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res 111:1002\u20131011. \nhttps:\/\/doi.org\/10.1161\/circresaha.112.270827","journal-title":"Circ Res"},{"key":"9800_CR38","doi-asserted-by":"publisher","first-page":"H1179","DOI":"10.1152\/ajpheart.00725.2003","volume":"287","author":"RH Ritchie","year":"2004","unstructured":"Ritchie RH, Rosenkranz AC, Huynh LP, Stephenson T, Kaye DM, Dusting GJ (2004) Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling. Am J Physiol Heart Circ Physiol 287:H1179\u2013H1185. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00725.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9800_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cardiores.2004.04.031","volume":"63","author":"G Selvetella","year":"2004","unstructured":"Selvetella G, Hirsch E, Notte A, Tarone G, Lembo G (2004) Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 63:373\u2013380. \nhttps:\/\/doi.org\/10.1016\/j.cardiores.2004.04.031","journal-title":"Cardiovasc Res"},{"key":"9800_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pharmthera.2009.08.001","volume":"124","author":"RH Ritchie","year":"2009","unstructured":"Ritchie RH, Irvine JC, Rosenkranz AC, Patel R, Wendt IR, Horowitz JD, Kemp-Harper BK (2009) Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond. Pharmacol Ther 124:279\u2013300. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2009.08.001","journal-title":"Pharmacol Ther"},{"key":"9800_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191\u2013227. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2010.04.005","journal-title":"Pharmacol Ther"},{"key":"9800_CR42","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1476-5381.2010.01043.x","volume":"162","author":"Q Xu","year":"2011","unstructured":"Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie RH, Sim K, Gao XM, Drummond G, Sarwar M, Zhang YY, Dart AM, du XJ (2011) Myocardial oxidative stress contributes to transgenic beta(2)-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 162:1012\u20131028. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2010.01043.x","journal-title":"Br J Pharmacol"},{"key":"9800_CR43","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","volume":"104","author":"NH Purcell","year":"2007","unstructured":"Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J et al (2007) Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl Acad Sci U S A 104:14074\u201314079. \nhttps:\/\/doi.org\/10.1073\/pnas.0610906104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9800_CR44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1160\/th05-01-0062","volume":"94","author":"E Bermejo","year":"2005","unstructured":"Bermejo E, Saenz DA, Alberto F, Rosenstein RE, Bari SE, Lazzari MA (2005) Effect of nitroxyl on human platelets function. Thromb Haemost 94:578\u2013584. \nhttps:\/\/doi.org\/10.1160\/th05-01-0062","journal-title":"Thromb Haemost"},{"key":"9800_CR45","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1073\/pnas.1011811108","volume":"108","author":"C Taflin","year":"2011","unstructured":"Taflin C, Favier B, Baudhuin J, Savenay A, Hemon P, Bensussan A, Charron D, Glotz D, Mooney N (2011) Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A 108:2891\u20132896. \nhttps:\/\/doi.org\/10.1073\/pnas.1011811108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9800_CR46","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1089\/ars.2007.2014","volume":"10","author":"Z Hertelendi","year":"2008","unstructured":"Hertelendi Z, Toth A, Borbely A, Galajda Z, van der Velden J, Stienen GJ et al (2008) Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and its Ca2+ sensitivity in human cardiomyocytes. Antioxid Redox Signal 10:1175\u20131184. \nhttps:\/\/doi.org\/10.1089\/ars.2007.2014","journal-title":"Antioxid Redox Signal"},{"key":"9800_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/circresaha.108.188441","volume":"104","author":"S Lancel","year":"2009","unstructured":"Lancel S, Zhang J, Evangelista A, Trucillo MP, Tong X, Siwik DA, Cohen RA, Colucci WS (2009) Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674. Circ Res 104:720\u2013723. \nhttps:\/\/doi.org\/10.1161\/circresaha.108.188441","journal-title":"Circ Res"},{"key":"9800_CR48","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS et al (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. Jama 287:1541\u20131547","journal-title":"Jama"},{"key":"9800_CR49","doi-asserted-by":"publisher","first-page":"13150","DOI":"10.1021\/bi801925p","volume":"47","author":"JP Froehlich","year":"2008","unstructured":"Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, Toscano JP (2008) Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47:13150\u201313152. \nhttps:\/\/doi.org\/10.1021\/bi801925p","journal-title":"Biochemistry"},{"key":"9800_CR50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1113\/jphysiol.2007.129254","volume":"580","author":"T Dai","year":"2007","unstructured":"Dai T, Tian Y, Tocchetti CG, Katori T, Murphy AM, Kass DA, Paolocci N, Gao WD (2007) Nitroxyl increases force development in rat cardiac muscle. J Physiol 580:951\u2013960. \nhttps:\/\/doi.org\/10.1113\/jphysiol.2007.129254","journal-title":"J Physiol"},{"key":"9800_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/01.RES.0000152969.42117.ca","volume":"96","author":"T Katori","year":"2005","unstructured":"Katori T, Hoover DB, Ardell JL, Helm RH, Belardi DF, Tocchetti CG, Forfia PR, Kass DA, Paolocci N (2005) Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Circ Res 96:234\u2013243. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000152969.42117.ca","journal-title":"Circ Res"},{"key":"9800_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/cs20140759","volume":"129","author":"KL Andrews","year":"2015","unstructured":"Andrews KL, Lumsden NG, Farry J, Jefferis AM, Kemp-Harper BK, Chin-Dusting JP (2015) Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance. Clin Sci (Lond) 129:179\u2013187. \nhttps:\/\/doi.org\/10.1042\/cs20140759","journal-title":"Clin Sci (Lond)"},{"key":"9800_CR53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","volume":"29","author":"JC Irvine","year":"2008","unstructured":"Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, Kemp-Harper BK (2008) Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci 29:601\u2013608. \nhttps:\/\/doi.org\/10.1016\/j.tips.2008.08.005","journal-title":"Trends Pharmacol Sci"},{"key":"9800_CR54","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1124\/mol.109.059915","volume":"76","author":"A Zeller","year":"2009","unstructured":"Zeller A, Wenzl MV, Beretta M, Stessel H, Russwurm M, Koesling D, Schmidt K, Mayer B (2009) Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli\u2019s salt. Mol Pharmacol 76:1115\u20131122. \nhttps:\/\/doi.org\/10.1124\/mol.109.059915","journal-title":"Mol Pharmacol"},{"key":"9800_CR55","doi-asserted-by":"publisher","first-page":"H1274","DOI":"10.1152\/ajpheart.00008.2009","volume":"296","author":"JL Favaloro","year":"2009","unstructured":"Favaloro JL, Kemp-Harper BK (2009) Redox variants of NO (NO {middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Am J Physiol Heart Circ Physiol 296:H1274\u2013H1280. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00008.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9800_CR56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","volume":"73","author":"JL Favaloro","year":"2007","unstructured":"Favaloro JL, Kemp-Harper BK (2007) The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc Res 73:587\u2013596. \nhttps:\/\/doi.org\/10.1016\/j.cardiores.2006.11.018","journal-title":"Cardiovasc Res"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09800-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09800-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09800-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:19:04Z","timestamp":1588807144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09800-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9800"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09800-6","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"8 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent is not applicable in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}